Osteoporosis Medication Administration Procedure Note (Injection/Infusion)

Date/Time: [Encounter date and start time]

Location: [Clinic or infusion center]

Ordering Clinician: [Name, credentials]

Administering Clinician: [Name, credentials (RN / pharmacist / MD / APP)]

Procedure Summary

[Medication name: generic (brand)] — [subcutaneous injection / IV infusion / IV push] for [indication]. [Dosing interval]. Last dose: [Date] (If unknown, document best available source). Today's dose: [on schedule / early / late]. Planned next dose: [Target date] (Allowable window: [Date range]).

Interval History and Safety Screen

(Document as focused checklist; add brief details only for positive findings.)

• Fractures or falls since last dose: [No / Yes: brief details]
• Dental history: Recent or planned dental procedures/oral surgery [No / Yes: brief details]; jaw pain, non-healing oral lesions, or exposed bone [No / Yes: brief details]
• Thigh/hip/groin pain (atypical femur fracture screen): [No / Yes: brief details]
• Infection screen: Recent skin infection, cellulitis, or hospitalization for infection [No / Yes: brief details]
• Renal status/medication changes: [No changes / Changes: brief details]
• Pregnancy status: [Not applicable / Not pregnant / Pregnant: action taken] (Include only if applicable to patient and therapy.)

Pre-administration verification: Correct patient, medication, dose, route, and timing verified. Allergies reviewed: [None / Allergies listed: brief]. Calcium/vitamin D supplementation: [Taking as prescribed / Not taking / Unknown: plan].

Denosumab-specific: (Include only if denosumab administered.)

• Hypocalcemia status: [No hypocalcemia / Corrected prior to administration: brief details]
• Advanced CKD/dialysis post-dose calcium monitoring plan: [Timeframe] with [Responsible clinician] (Include only for patients with advanced CKD or on dialysis.)
• Pregnancy ruled out: [Yes / No: action] (Include only for patients of reproductive potential.)

IV bisphosphonate-specific: (Include only if IV zoledronic acid or IV ibandronate administered.)

• Renal function reviewed: Creatinine [Value, Date]; [eGFR / CrCl] [Value, Date]
• Hydration status: [Adequate / Inadequate: action]
• Hypocalcemia and vitamin D deficiency addressed: [Yes / No: action]
• Oral exam/dental risk assessment completed at initiation; interval dental risk reviewed today: [Yes / No: action]

Safety labs availability: [Up-to-date / Unavailable or outdated: action taken (e.g., labs ordered and administration deferred, external labs reviewed with date and values)]

Labs Reviewed

(List only medication-relevant results with value, units, and date.)

• Calcium: [Value, Units, Date] [Albumin-corrected: Value] (Note if corrected.)
• 25-OH Vitamin D: [Value, Units, Date] (Include if used for risk stratification.)
• Serum creatinine: [Value, Units, Date]; [eGFR / CrCl]: [Value, Units, Date]
• Phosphorus/Magnesium: [Value, Units, Date] (Include only if indicated by patient risk factors.)
• CKD-MBD markers: [Values and dates] (Include only for dialysis patients on denosumab.)

Counseling and Consent

Indication and expected benefit discussed. Material risks reviewed: hypocalcemia symptoms and when to seek care, osteonecrosis of the jaw warning signs and dental precautions, atypical femur fracture prodromal symptoms. [For IV bisphosphonates: acute phase reaction counseling and mitigation plan discussed.] [For denosumab: importance of on-time dosing emphasized.] Patient's questions addressed. Patient [agreed to proceed / declined: document reason, capacity assessment, and follow-up plan]. Medication guide [provided / not provided].

Administration Details

• Medication: [Generic (Brand)]
• Dose: [mg]
• Volume: [mL]
• Route: [SC / IV infusion / IV push]
• Site: [Anatomic location for SC; vein location and side for IV]
• Lot number: [Number]
• Expiration: [Date]
• Visual inspection: Product inspected and acceptable [Yes / No: details]

Subcutaneous injection: (Include only if SC administered.) Site prepared with [agent]. Immediate tolerance: [Well tolerated / Pain / Bleeding / Bruising: brief details].

IV access: (Include for IV infusion or IV push.) Access type: [Peripheral / Central / Port]; gauge: [#]; location: [site]; patency confirmed: [Yes / No: action].

IV infusion timing: (Include only if IV infusion administered. Capture actual infusion time only, not waiting or ancillary tasks.) Diluent and volume: [Specify]. Start time: [HH:MM]; Stop time: [HH:MM]; Total duration: [minutes]. Minimum required infusion duration met: [Yes / No]. Interruptions or complications: [None / Describe]. (If times are in nursing flowsheet or MAR, reference that location.)

IV push timing: (Include only if IV push administered.) Start time: [HH:MM]; Stop time: [HH:MM]; Total duration: [minutes].

Monitoring and Tolerance

Observation period: [Duration]. Baseline vitals: [Values or "per flowsheet"] (Include if required by local protocol.)

[No immediate adverse reaction; medication tolerated well. / Adverse event occurred: signs/symptoms, onset timing, severity, interventions, response, and disposition.]

Assessment

[Primary diagnosis] treated with [medication] administered today [without complication / with complication: brief description].

[Secondary safety assessments if relevant: renal function acceptable for administration, calcium/vitamin D plan reviewed, dental risk screen completed.]

Plan

• Next scheduled dose: [Date] (Allowable window: [Date range])
• Pre-next-dose labs: [Labs, timing, ordering clinician, reviewer]
• High-risk hypocalcemia monitoring: [Post-dose calcium check timing] with [Responsible clinician] (Include only for high-risk patients.)
• Follow-up appointments: [Clinic/Provider, Date or scheduling instructions] (Include if relevant.)
• Therapy transition: [Discontinue / transition to alternative agent]; [Transition plan, responsible prescriber, timeframe] (Include only if therapy is being changed.)

(If a separately billable E/M service was performed beyond routine pre-administration assessment, document that evaluation distinctly per local policy.)

Signature

[Administering clinician signature and credentials]